DOI QR코드

DOI QR Code

Constitutive stabilization of hypoxia-inducible factor alpha selectively promotes the self-renewal of mesenchymal progenitors and maintains mesenchymal stromal cells in an undifferentiated state

  • Park, In-Ho (Catholic High-Performance Cell Therapy Center and Department of Medical Lifescience, The Catholic University of Korea, College of Medicine) ;
  • Kim, Kwang-Ho (Catholic High-Performance Cell Therapy Center and Department of Medical Lifescience, The Catholic University of Korea, College of Medicine) ;
  • Choi, Hyun-Kyung (Catholic High-Performance Cell Therapy Center and Department of Medical Lifescience, The Catholic University of Korea, College of Medicine) ;
  • Shim, Jae-Seung (Catholic High-Performance Cell Therapy Center and Department of Medical Lifescience, The Catholic University of Korea, College of Medicine) ;
  • Whang, Soo-Young (Catholic High-Performance Cell Therapy Center and Department of Medical Lifescience, The Catholic University of Korea, College of Medicine) ;
  • Hahn, Sang June (Department of Physiology, The Catholic University of Korea, College of Medicine) ;
  • Kwon, Oh-Joo (Department of Biochemistry, The Catholic University of Korea, College of Medicine) ;
  • Oh, Il-Hoan (Catholic High-Performance Cell Therapy Center and Department of Medical Lifescience, The Catholic University of Korea, College of Medicine)
  • 발행 : 2013.09.30

초록

With the increasing use of culture-expanded mesenchymal stromal cells (MSCs) for cell therapies, factors that regulate the cellular characteristics of MSCs have been of major interest. Oxygen concentration has been shown to influence the functions of MSCs, as well as other normal and malignant stem cells. However, the underlying mechanisms of hypoxic responses and the precise role of hypoxia-inducible factor-$1{\alpha}$ (Hif-$1{\alpha}$), the master regulatory protein of hypoxia, in MSCs remain unclear, due to the limited span of Hif-$1{\alpha}$ stabilization and the complex network of hypoxic responses. In this study, to further define the significance of Hif-$1{\alpha}$ in MSC function during their self-renewal and terminal differentiation, we established adult bone marrow (BM)-derived MSCs that are able to sustain high level expression of ubiquitin-resistant Hif-$1{\alpha}$ during such long-term biological processes. Using this model, we show that the stabilization of Hif-$1{\alpha}$ proteins exerts a selective influence on colony-forming mesenchymal progenitors promoting their self-renewal and proliferation, without affecting the proliferation of the MSC mass population. Moreover, Hif-$1{\alpha}$ stabilization in MSCs led to the induction of pluripotent genes (oct-4 and klf-4) and the inhibition of their terminal differentiation into osteogenic and adipogenic lineages. These results provide insights into the previously unrecognized roles of Hif-$1{\alpha}$ proteins in maintaining the primitive state of primary MSCs and on the cellular heterogeneities in hypoxic responses among MSC populations.

키워드

참고문헌

  1. Keating A. Mesenchymal stromal cells. Curr Opin Hematol 2006; 13: 419-425. https://doi.org/10.1097/01.moh.0000245697.54887.6f
  2. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147. https://doi.org/10.1126/science.284.5411.143
  3. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-74. https://doi.org/10.1126/science.276.5309.71
  4. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006; 98: 1076-1084. https://doi.org/10.1002/jcb.20886
  5. Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 2007; 211: 27-35. https://doi.org/10.1002/jcp.20959
  6. Dezawa M, Hoshino M, Ide C. Treatment of neurodegenerative diseases using adult bone marrow stromal cell-derived neurons. Expert Opin Biol Ther 2005; 5: 427-435. https://doi.org/10.1517/14712598.5.4.427
  7. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 2002; 99: 8932-8937. https://doi.org/10.1073/pnas.132252399
  8. Jorgensen C, Gordeladze J, Noel D. Tissue engineering through autologous mesenchymal stem cells. Curr Opin Biotechnol 2004; 15: 406-410. https://doi.org/10.1016/j.copbio.2004.08.003
  9. Magne D, Vinatier C, Julien M, Weiss P, Guicheux J. Mesenchymal stem cell therapy to rebuild cartilage. Trends Mol Med 2005; 11: 519-526. https://doi.org/10.1016/j.molmed.2005.09.002
  10. Kim DW, Chung YJ, Kim TG, Kim YL, Oh IH. Cotransplantation of thirdparty mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 2004; 103: 1941-1948. https://doi.org/10.1182/blood-2003-05-1601
  11. Noort WA, Kruisselbrink AB, in't Anker PS, Kruger M, van Bezooijen RL, de Paus RA et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2002; 30: 870-878. https://doi.org/10.1016/S0301-472X(02)00820-2
  12. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-1441. https://doi.org/10.1016/S0140-6736(04)16104-7
  13. Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H et al. Mesenchymal stem cells for treatment of therapy-resistant graftversus- host disease. Transplantation 2006; 81: 1390-1397. https://doi.org/10.1097/01.tp.0000214462.63943.14
  14. Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA 2001; 98: 7841-7845. https://doi.org/10.1073/pnas.141221698
  15. Kucia MHM, Wsoczynski M, Baskiewicz-Masiuk M, Zuba-Surma E, Machalinski B et al. A novel population of Oct-4+ SSEA-1+ CXCR4+ CD34+ CD133+ Lin- CD45- very smal embryonic-like (VSEL) stem cells identified in human cord blood. Blood 2006; 108: 912a.
  16. Smith JR, Pochampally R, Perry A, Hsu SC, Prockop DJ. Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma. Stem Cells 2004; 22: 823-831. https://doi.org/10.1634/stemcells.22-5-823
  17. Vacanti V, Kong E, Suzuki G, Sato K, Canty JM, Lee T. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J Cell Physiol 2005; 205: 194-201. https://doi.org/10.1002/jcp.20376
  18. Larson BL, Ylostalo J, Prockop DJ. Human multipotent stromal cells undergo sharp transition from division to development in culture. Stem Cells 2008; 26: 193-201. https://doi.org/10.1634/stemcells.2007-0524
  19. Simon MC, Keith B. The role of oxygen availability in embryonic development and stem cell function. Nat Rev Mol Cell Biol 2008; 9: 285-296. https://doi.org/10.1038/nrm2354
  20. Semenza G. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721-732. https://doi.org/10.1038/nrc1187
  21. Keith B, Simon M. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007; 129: 465-472. https://doi.org/10.1016/j.cell.2007.04.019
  22. Wouters BG, Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 2008; 8: 851-864. https://doi.org/10.1038/nrc2501
  23. Kallio P, Wilson W, O'Brien S, Makino Y, Poellinger L. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem 1999; 274: 6519-6525. https://doi.org/10.1074/jbc.274.10.6519
  24. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001; 292: 464-468. https://doi.org/10.1126/science.1059817
  25. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292: 468-472. https://doi.org/10.1126/science.1059796
  26. Masson N, Willam C, Maxwell P, Pugh C, Ratcliffe P. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J 2001; 20: 5197-5206. https://doi.org/10.1093/emboj/20.18.5197
  27. Ren H, Cao Y, Zhao Q, Li J, Zhou C, Liao L et al. Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions. Biochem Biophys Res Commun 2006; 347: 12-21. https://doi.org/10.1016/j.bbrc.2006.05.169
  28. Rosova I, Dao M, Capoccia B, Link D, Nolta J. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 2008; 26: 2173-2182. https://doi.org/10.1634/stemcells.2007-1104
  29. Crisostomo P, Wang Y, Markel TA, Wang M, Lahm T, Meldrum DR. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol 2008; 294: C675-C682. https://doi.org/10.1152/ajpcell.00437.2007
  30. Fehrer C, Brunauer R, Laschober G, Unterluggauer H, Reitinger S, Kloss F et al. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 2007; 6: 745-757. https://doi.org/10.1111/j.1474-9726.2007.00336.x
  31. Kinnaird T, Stabile E, Burnett M, Epstein S. Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circ Res 2004; 95: 354-363. https://doi.org/10.1161/01.RES.0000137878.26174.66
  32. Grayson W, Zhao F, Bunnell B, Ma T. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun 2007; 358: 948-953. https://doi.org/10.1016/j.bbrc.2007.05.054
  33. Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med 2004; 36: 1-12. https://doi.org/10.1038/emm.2004.1
  34. Zhang D, Li J, Costa M, Gao J, Huang C. JNK1 mediates degradation HIF- 1alpha by a VHL-independent mechanism that involves the chaperones Hsp90/Hsp70. Cancer Res 2010; 70: 813-823. https://doi.org/10.1158/0008-5472.CAN-09-0448
  35. Flugel D, Gorlach A, Michiels C, Kietzmann T. Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner. Mol Cell Biol 2007; 27: 3253-3265. https://doi.org/10.1128/MCB.00015-07
  36. D'Ippolito G, Diabira S, Howard GA, Roos BA, Schiller PC. Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone 2006; 39: 513-522. https://doi.org/10.1016/j.bone.2006.02.061
  37. Floyd ZE, Kilroy G, Wu X, Gimble JM. Effects of prolyl hydroxylase inhibitors on adipogenesis and hypoxia inducible factor 1 alpha levels under normoxic conditions. J Cell Biochem 2007; 101: 1545-1557. https://doi.org/10.1002/jcb.21266
  38. Irwin R, LaPres JJ, Kinser S, McCabe LR. Prolyl-hydroxylase inhibition and HIF activation in osteoblasts promotes an adipocytic phenotype. J Cell Biochem 2007; 100: 762-772. https://doi.org/10.1002/jcb.21083
  39. Lin Q, Lee YJ, Yun Z. Differentiation arrest by hypoxia. J Biol Chem 2006; 281: 30678-30683. https://doi.org/10.1074/jbc.C600120200
  40. Tamama K, Kawasaki H, Kerpedjieva SS, Guan J, Ganju RK, Sen CK. Differential roles of hypoxia inducible factor subunits in multipotential stromal cells under hypoxic condition. J Cell Biochem 2011; 112: 804-817. https://doi.org/10.1002/jcb.22961
  41. Kim D, Chung Y, Kim T, Kim Y, Oh I. Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 2004; 103: 1941-1948. https://doi.org/10.1182/blood-2003-05-1601
  42. Oh I, Eaves C. Overexpression of a dominant negative form of STAT3 selectively impairs hematopoietic stem cell activity. Oncogene 2002; 21: 4778-4787. https://doi.org/10.1038/sj.onc.1205592
  43. Oh I, Fabry ME, Humphries RK, Pawliuk R, Leboulch P, Hoffman R et al. Expression of an anti-sickling beta-globin in human erythroblasts derived from retrovirally transduced primitive normal and sickle cell disease hematopoietic cells. Exp Hematol 2004; 32: 461-469. https://doi.org/10.1016/j.exphem.2004.02.001
  44. Pittenger M, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147. https://doi.org/10.1126/science.284.5411.143
  45. Woodbury D, Schwarz E, Prockop D, Black I. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000; 61: 364-370. https://doi.org/10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C
  46. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patchclamp techniques for high-resolution current recording from cells and cellfree membrane patches. Pflugers Archiv 1981; 391: 85-100. https://doi.org/10.1007/BF00656997
  47. Ball SG, Shuttleworth A, Kielty CM. Inhibition of platelet-derived growth factor receptor signaling regulates Oct4 and Nanog expression, cell shape, and mesenchymal stem cell potency. Stem Cells 2012; 30: 548-560. https://doi.org/10.1002/stem.1015
  48. Tsai CC, Su PF, Huang YF, Yew TL, Hung SC. Oct4 and Nanog directly regulate Dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells. Mol Cell 2012; 47: 169-182. https://doi.org/10.1016/j.molcel.2012.06.020
  49. Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 2005; 309: 1074-1078. https://doi.org/10.1126/science.1110955
  50. Shomento SH, Wan C, Cao X, Faugere MC, Bouxsein ML, Clemens TL et al. Hypoxia-inducible factors 1alpha and 2alpha exert both distinct and overlapping functions in long bone development. J Cell Biochem 2010; 109: 196-204. https://doi.org/10.1002/jcb.22396
  51. Liu TM, Ng WM, Tan HS, Vinitha D, Yang Z, Fan JB et al. Molecular basis of immortalization of human mesenchymal stem cells by combination of p53 knockdown and human telomerase reverse transcriptase overexpression. Stem Cells Dev 2013; 22: 268-278. https://doi.org/10.1089/scd.2012.0222
  52. Okamoto T, Aoyama T, Nakayama T, Nakamata T, Hosaka T, Nishijo K et al. Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem Biophys Res Commun 2002; 295: 354-361. https://doi.org/10.1016/S0006-291X(02)00661-7
  53. Marxsen JH, Stengel P, Doege K, Heikkinen P, Jokilehto T, Wagner T et al. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J 2004; 381: 761-767. https://doi.org/10.1042/BJ20040620
  54. Pacary E, Legros H, Valable S, Duchatelle P, Lecocq M, Petit E et al. Synergistic effects of CoCl(2) and ROCK inhibition on mesenchymal stem cell differentiation into neuron-like cells. J Cell Sci 2006; 119: 2667-2678. https://doi.org/10.1242/jcs.03004
  55. Bronner ME, LeDouarin NM. Development and evolution of the neural crest: an overview. Dev Biol 2012; 366: 2-9. https://doi.org/10.1016/j.ydbio.2011.12.042
  56. Dupin E, Sommer L. Neural crest progenitors and stem cells: from early development to adulthood. Dev Biol 2012; 366: 83-95. https://doi.org/10.1016/j.ydbio.2012.02.035
  57. Wislet-Gendebien S, Laudet E, Neirinckx V, Alix P, Leprince P, Glejzer A et al. Mesenchymal stem cells and neural crest stem cells from adult bone marrow: characterization of their surprising similarities and differences. Cell Mol Life Sci 2012; 69: 2593-2608. https://doi.org/10.1007/s00018-012-0937-1

피인용 문헌

  1. EphA3 biology and cancer vol.32, pp.6, 2014, https://doi.org/10.3109/08977194.2014.982276
  2. Hypoxic Preconditioning of Mesenchymal Stromal Cells Induces Metabolic Changes, Enhances Survival, and Promotes Cell Retention In Vivo vol.33, pp.6, 2013, https://doi.org/10.1002/stem.1976
  3. Acute Hypoxic Stress Affects Migration Machinery of Tissue O 2 -Adapted Adipose Stromal Cells vol.2016, pp.None, 2013, https://doi.org/10.1155/2016/7260562
  4. Effects of CoCl2 on multi-lineage differentiation of C3H/10T1/2 mesenchymal stem cells vol.20, pp.1, 2013, https://doi.org/10.4196/kjpp.2016.20.1.53
  5. Hypoxia Inducible Factor 1 Alpha Is Expressed in Germ Cells throughout the Murine Life Cycle vol.11, pp.5, 2013, https://doi.org/10.1371/journal.pone.0154309
  6. Targeting the hypoxic response in bone tissue engineering: A balance between supply and consumption to improve bone regeneration vol.432, pp.None, 2013, https://doi.org/10.1016/j.mce.2015.12.024
  7. Heterogeneous Niche Activity of Ex-Vivo Expanded MSCs as Factor for Variable Outcomes in Hematopoietic Recovery vol.11, pp.12, 2013, https://doi.org/10.1371/journal.pone.0168036
  8. Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression vol.26, pp.18, 2017, https://doi.org/10.1089/ars.2016.6813
  9. Strategies to Enhance Implantation and Survival of Stem Cells After Their Injection in Ischemic Neural Tissue vol.26, pp.8, 2017, https://doi.org/10.1089/scd.2016.0268
  10. Hypoxic Culture Promotes Dopaminergic-Neuronal Differentiation of Nasal Olfactory Mucosa Mesenchymal Stem Cells via Upregulation of Hypoxia-Inducible Factor-1α vol.26, pp.8, 2013, https://doi.org/10.1177/0963689717720291
  11. Combination of betulinic acid and chidamide inhibits acute myeloid leukemia by suppression of the HIF1α pathway and generation of reactive oxygen species vol.8, pp.55, 2013, https://doi.org/10.18632/oncotarget.21889
  12. The Role of Dissolved Oxygen Levels on Human Mesenchymal Stem Cell Culture Success, Regulatory Compliance, and Therapeutic Potential vol.27, pp.19, 2013, https://doi.org/10.1089/scd.2017.0291
  13. Effects of HSYA on the proliferation and apoptosis of MSCs exposed to hypoxic and serum deprivation conditions vol.15, pp.6, 2013, https://doi.org/10.3892/etm.2018.6125
  14. Mathematical modelling of interacting mechanisms for hypoxia mediated cell cycle commitment for mesenchymal stromal cells vol.12, pp.1, 2013, https://doi.org/10.1186/s12918-018-0560-3
  15. Mechanism of the natural product moracin-O derived MO-460 and its targeting protein hnRNPA2B1 on HIF-1α inhibition vol.51, pp.2, 2013, https://doi.org/10.1038/s12276-018-0200-4
  16. Relevance of Oxygen Concentration in Stem Cell Culture for Regenerative Medicine vol.20, pp.5, 2013, https://doi.org/10.3390/ijms20051195
  17. HIF1α‐mediated AIMP3 suppression delays stem cell aging via the induction of autophagy vol.18, pp.2, 2013, https://doi.org/10.1111/acel.12909
  18. Can Hypoxic Conditioning Improve Bone Metabolism? A Systematic Review vol.16, pp.10, 2019, https://doi.org/10.3390/ijerph16101799
  19. Mesenchymal stem cells: Cell therapy and regeneration potential vol.13, pp.9, 2013, https://doi.org/10.1002/term.2914
  20. Effects of Hypoxia on Differentiation of Mesenchymal Stem Cells vol.15, pp.4, 2013, https://doi.org/10.2174/1574888x14666190823144928
  21. Type I collagen facilitates safe and reliable expansion of human dental pulp stem cells in xenogeneic serum-free culture vol.11, pp.1, 2013, https://doi.org/10.1186/s13287-020-01776-7
  22. HIF1α/HIF2α-Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K/AKT signalling pathway with positive feedback under hypoxia vol.12, pp.4, 2013, https://doi.org/10.1038/s41419-021-03598-8
  23. α-Tocopherol Acetate Attenuates Mitochondrial Oxygen Consumption and Maintains Primitive Cells within Mesenchymal Stromal Cell Population vol.17, pp.4, 2013, https://doi.org/10.1007/s12015-020-10111-9